Tampa, FL – Dr. Claudio Anasetti of H. Lee Moffitt Cancer Center & Research Institute has been chosen to serve as the Vice President of the American Society of Blood and Marrow Transplantation (ASBMT). The office places him in line to assume the presidency two years from now. Anasetti is program leader of the Blood and Marrow Transplant Program at Moffitt.
ASBMT is a national professional association that promotes advancement of the field of blood and bone marrow transplantation. ASBMT members are both in clinical practice and in research.
Anasetti came to Moffitt in 2004 from the Fred Hutchinson Cancer Research Center in Seattle, where he served as Professor of Medicine and Oncology and Medical Director of the Unrelated Donor Marrow Transplant Program. In addition, he was an attending physician in Oncology and BMT at the University of Washington Medical Center and the Seattle Cancer Care Alliance.
Anasetti is internationally recognized for his work in hematological malignancy and other disorders and their treatment with blood or marrow stem cell transplantation. He holds two U.S. patents for radiation delivery to lymphoid and marrow tissues and specific antibody compositions for use in methods of immunosuppression.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida on the University of South Florida campus, H. Lee Moffitt Cancer Center & Research Institute (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.